health
fluidlab 1

Automated urine microscopy for point-of-care diagnostics

health fluidlab 1

Automated urine microscopy for point-of-care diagnostics

Point-of-care relevance

Revolutionizing urine analysis at the point of care 

Urine microscopy remains one of the most commonly performed tests in clinical labs, essential for screening and monitoring urinary tract infections, kidney diseases and other conditions. Manual microscopy is time-consuming and requires skilled personnel, while existing automated analyzers are often expensive and bulky. 

The health fluidlab 1 uses cutting-edge holographic microscopy to perform automated urine particle analysis directly on uncentrifuged urine samples, eliminating the need for preparation steps and delivering fast, reliable results for point-of-care settings. 

Designed for everyday use

Smart handling & operational guidance

Acella-Slide sample carrier
Ensures precise sample volume and consistent measurement conditions.

Factory-calibrated optics
Factory-calibrated, no-moving-parts sensor ensures long-term stability.

On-device storage & data transfer
Stores up to 300 measurements; data export via Wi-Fi or hotspot.

Automatic software updates
Regular enhancements delivered via Wi-Fi.

How it works

From light to insight

Digital holographic microscopy is an advanced imaging technique that captures detailed, quantitative phase information without the need for stains or dyes. This non-invasive method reconstructs high-resolution 3D images of cells and particles, while preserving their natural state. 

1. Illumination

A coherent light source illuminates the sample. Microscopic objects in the optical path scatter the light.

2. Hologram

The scattered light interacts with the original wavefront, forming an interference pattern – the hologram.

3. Reconstruction

Algorithms reconstruct phase and amplitudes to create quantitative 3D images.

4. Classification

Machine learning models detect and classify cells and particles for the specific application.

Performance overview

Measurement capabilities and clinical applications 

Effortless
Ready to use, no centrifugation
Samll sample volume (20 µl)
Step-by-step guide on the device

Cost effective
Automated analysis
Low cost per test

Reliable & standardized
Consistent analysis not dependent on operator skill
No subjective interpretation
Reproducible results for routine diagnostics

Compact & maintenance-free
Handheld, portable design
No calibration needed
Sensor cleaning required only when indicated

Immediate
Low hands-on time (3 steps)
Fast reporting of results
Ideal for point-of-care decisions

Performance overview

Measurement capabilities and clinical applications 

Effortless
Ready to use, no centrifugation
Samll sample volume (20 µl)
Step-by-step guide on the device

Cost effective
Automated analysis
Low cost per test

Reliable & standardized
Consistent analysis not dependent on operator skill
No subjective interpretation
Reproducible results for routine diagnostics

Compact & maintenance-free
Handheld, portable design
No calibration needed
Sensor cleaning required only when indicated

Immediate
Low hands-on time (3 steps)
Fast reporting of results
Ideal for point-of-care decisions

expert perspective

Why point-of-care
diagnostics matter globally

“The expansion of point of care testing (POCT) in all areas of health care must be seen on a global scale. Particular attention must also be paid to the potential of POCT in developing countries. The rapid technical development of POCT analysis methods (keywords: nanotechnology, miniaturisation and parallelisation) increasingly allows even complex in vitro methods to be developed as POCT. One does not have to be a prophet to realise that the various POCT analytical methods – especially those with photonic readout procedures – are very likely to gain significant market shares due to their manifold (pre)analytical advantages.”

Prof. Dr. Peter B. Luppa
Institute for Clinical Chemistry and Pathobiochemistry
TUM Klinikum Rechts der Isar Technische Universität München

“The expansion of point of care testing (POCT) in all areas of health care must be seen on a global scale. Particular attention must also be paid to the potential of POCT in developing countries. The rapid technical development of POCT analysis methods (keywords: nanotechnology, miniaturisation and parallelisation) increasingly allows even complex in vitro methods to be developed as POCT. One does not have to be a prophet to realise that the various POCT analytical methods – especially those with photonic readout procedures – are very likely to gain significant market shares due to their manifold (pre)analytical advantages.”

Prof. Dr. Peter B. Luppa
Institute for Clinical Chemistry and Pathobiochemistry
TUM Klinikum Rechts der Isar Technische Universität München

Want to
learn more?

If you’re exploring point-of-care urine microscopy or considering the health fluidlab 1 for your workflow, our team is happy to support you.

Whether you need technical details, workflow guidance or want to discuss integration options — we’re here to help.

Contact us
FAQ

We answer your questions

Scroll to Top